Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Showing session: reset

HIV ANTIVIRALS AND OUTCOMES

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 9 of 9
IMPROVING INTESTINAL BARRIER USING GLP-2 AGONIST REDUCES ARTERIAL INFLAMMATION IN PWH   (ABSTRACT 134)
Janet Lo
Massachusetts General Hospital, Boston, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
DOLUTEGRAVIR WITH RECYCLED NRTIS IS NONINFERIOR TO PI-BASED ART: VISEND TRIAL   (ABSTRACT 135)
Lloyd B Mulenga
University Teaching Hospital, Lusaka, Zambia
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
A RANDOMIZED TRIAL OF SWITCHING TREATMENT-EXPERIENCED ADULTS FROM PI/R TO DTG   (ABSTRACT 136)
Loice A Ombajo
University of Nairobi, Nairobi, Kenya
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
NUCLEOSIDES AND DARUNAVIR/DOLUTEGRAVIR IN AFRICA (NADIA) TRIAL: OUTCOMES AT 96 WEEKS   (ABSTRACT 137)
Nicholas Paton
National University of Singapore, Singapore, Singapore
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Janet Lo
Massachusetts General Hospital, Boston, MA, USA
Joseph J Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Lloyd B Mulenga
University Teaching Hospital, Lusaka, Zambia
Loice A Ombajo
University of Nairobi, Nairobi, Kenya
Nicholas Paton
National University of Singapore, Singapore, Singapore
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LENACAPAVIR AS PART OF A COMBINATION REGIMEN IN TREATMENT NAIVE PWH: WEEK 54 RESULTS   (ABSTRACT 138)
Samir Gupta
Indiana University School of Medicine, Indianapolis, IN, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
VIRAL ESCAPE DURING TRIPLE BROADLY NEUTRALIZING ANTIBODY THERAPY AGAINST HIV-1   (ABSTRACT 139)
Boris Juelg
Massachusetts General Hospital, Cambridge, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
PHASE I STUDY OF LONG-ACTING 3BNC117 AND 10-1074 IN VIREMIC ADULTS LIVING WITH HIV   (ABSTRACT 140)
Marina Caskey
The Rockefeller University, New York, NY, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Marina Caskey
The Rockefeller University, New York, NY, USA
Angela Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Samir Gupta
Indiana University School of Medicine, Indianapolis, IN, USA
Boris Juelg
Massachusetts General Hospital, Cambridge, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 9 of 9